Improving Prevention of Strokes: New Developments in the Field of Early Detection of Afib
AFib is the leading cause of stroke, contributing to 20%-30% of all strokes1 Furthermore, strokes from this condition are more disabling and more often fatal than strokes with other causes2. Consequences of strokes can severely compromise the survivor’s ability to live their life at the fullest, as a stroke happens in the brain, the control centre for who we are and what we can do.
While AFib can present no subjective symptoms in many cases, those commonly associated with the condition include3palpitations (being aware of your heart beating fast), breathlessness, chest pain and fatigue.
Join the discussion about how we can improve the prevention of strokes: the scientific relevance, patients at risk, as well as examples of patient cases. Ask a question during the Q&A.
This broadcast is supported by:
Welcome and Introduction
ESC2020 guidelines for diagnosis and management of atrial fibrillation explained
Prof Faizel Osman
Early detection of AFib: crucial in the prevention of strokes
Patients’ experiences using OMRON Complete and its role in self-management of Atrial Fibrillation
Key Learning Objectives
- Defining and diagnosing AF
- Risk factors in AF
- Stroke prevention in AF
- Treatment options available for the AF
- Latest ESC guidance
- General Practitioners
- Practice Nurses
- GPs with special interest in cardiology
- Hypertension specialists
Prof Dr Osman is Consultant Cardiologist / Electrophysiologist, University Hospital Coventry, UK, Honorary Professor of Cardiology (Warwick Medical School)
Lead for Cardiac Rhythm Management Several research interests in the field of arrhythmia, including CRT response, AF and Ablation.
Special interest: Cardiac Electrophysiology: Atrial Fibrillation, SVT, Atrial Flutter, Ventricular Arrhythmias Complex Devices: ICD, CRT Bradycardia Pacemakers Leadless Pacemakers Device Extractions.
He holds specialist accreditations from several organisations including Heart Rhythm UK, International Board of Heart Rhythm Examiners (US) and the European Heart Rhythm Association (EHRA).
Dr Barry McDonnell is a Reader in Cardiovascular Physiology. His research programme aims to understand the interactions between blood pressure and large artery haemodynamics in the development and progression of cardiovascular disease. Through his collaborative research, Barry has been awarded funding through competitive national and international funding streams (e.g. EU Horizon2020, British Heart Foundation, Health and Care Research Wales & National Institute for Health (US)). Dr McDonnell leads the Cardiff Met. Cardiovascular Physiology Research and Innovation Group and the UK and Ireland’s May Measurement Month (MMM) blood pressure awareness campaign. Barry is currently working as the Work Group-1 vice-lead for the European Cost Action - Vascular Ageing Network, and is editor for the journal Artery Research.
Lucy is Innovation Lead at University Hospitals Coventry and Warwickshire NHS Trust. Starting her career in academia, before moving to NHS Improvement, Lucy enjoys combining her background in psychology, human factors, research, Quality Improvement methodology and change management theory to support all aspects of Innovation, from creativity and design, through to evaluation and implementation. Lucy leads the Innovation Team at UHCW who take staff ideas from inception through to commercialization. The team also support the development, evaluation, adoption and spread of innovations from companies and entrepreneurs.
Dr Javaid qualified from Cambridge University and completed his GP VTS training in Northampton. He has an interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease.
Dr Javaid was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is also a council member of the British Heart Valve Society, accredited member of the British Society of Echocardiography and on the editorial board for the British Journal of Cardiology.
1. European Society of Cardiology https://www.escardio.org/The-ESC/Press-Office/Press-releases/Atrial-fibrillation-set-to-affect-more-than-14-million-over-65s-in-the-EU-by-2060
2. ESC Guidelines 2020 for diagnosis and management of atrial fibrillation.
3. Esato M, Chun YH, An Y, et al. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry. Chest. 2017;152(6):1266-1275.